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Summary          
Undisturbed nasal breathing is essential for normal breathing physiology as a whole. 
Nasal septal deformities (NSD) are well known as a factor which can remarkably and 
substantially affect the quality of nasal and pulmonary breathing. However, it is well 
known that type 5 and type 6 nasal septal deformities may cause only a moderate, 
unilateral nasal obstruction or none at all. The effects of nasal obstruction on the 
respiratory and cardiovascular systems have been well studied so far: right ventricle 
problems, ischemic heart diseases, sleep disorders, mucociliary clearance system 
disturbances, paranasal sinus pathology, have all been described as a result of 
impaired nasal breathing. The connection between the upper and lower respiratory 
systems has been recognized in allergic rhinitis and asthma as well, resulting in the 
united airways concept. Most recently, the ostensible connection between chronic 
rhinosinusitis (CRS) and acute myocardial infarction has been said to be proven. 
However, the results of this study might have not been well founded since there are 
no direct and clear proofs that CRS as a chronic inflammatory process has anything 
to do with the acute coronary syndrome (ACS). On the other hand, a large 
international study on the incidence of NSD in CRS patients, based on the Mladina 
classification, showed that NSD were present in a high incidence and that the most 
frequent deformities were types 5 (36.18%) and 7 (29.92%). The vast majority of 
those types 7 consisted of types 3 and (again) types 5 or types 6 (76.32%). The fact 
that in CRS patients a remarkably high incidence of type 5 septal deformity can be 
seen, gives rise to thinking that this factor perhaps plays a role in the onset of ACS. 
Acute coronary syndrome is one of the leading causes of death all over the world. 
Traditional risk factors such as family history, overweight body, smoking, stress, 
hypertension, hypercholesterolemia, diabetes mellitus, coronary artery calcium score, 
C-reactive protein, lipoprotein, homocysteine, lipoprotein-associated phospholipase 
A2, as well as high-density lipoprotein functionality perhaps cannot account for the 
entire risk for incident coronary events. Several other potential risk factors have been 
identified in an effort to improve risk assessment for ACS. This article reviews one of 
them: the possible influence of an unusual, so far unknown predisposing factor: type 
5 or type 6 nasal septal deformities. They have been found as pure, isolated types or 
as a part of combined nasal septal deformity (type 7).   
Introduction 
            Undisturbed nasal breathing is essential for normal breathing physiology as a 
whole and the effects of nasal obstruction on the respiratory and cardiovascular 
systems have been well studied: right ventricle problems1,2, ischemic heart 
diseases3,4,5,,6,7,8,9, sleep disorders10,11,12,13, mucociliary clearance system 
disturbances14,15, paranasal sinus pathology16,17, have all  been described as a result 
of impaired nasal breathing. The connection between the upper and lower respiratory 
systems has been recognized in allergic rhinitis and asthma as well, resulting in 
united airways concept. A concept of treating the upper airway pathology in order to 
improve pathology of the lower airways and vice versa changed and improved 
treatment results. Surgical treatment of the nasal obstruction has a positive effect on 
pulmonary function tests18 and on quality of life in general19. Ogretmenoglu and his 
group showed that even light bilateral nasal packing has a strong influence on arterial 
blood gases and heart rate20.The connection between particular types of nasal septal 
deformities (NSD) and minimal cross-sectional area of the nasal cavity and body 
surface area has been confirmed ten years ago21. Most recently, the ostensible 
connection between chronic rhinosinusitis (CRS) and acute myocardial infarction has 
been proven22. Focal accumulation of fluids containing proinflammatory cytokines 
and altered activation of the coagulation system in the paranasal sinuses has been 
reported in CRS patients23, 24. Besides, some hypotheses proposed that exposure to 
these proinflammatory cytokines may trigger juxtavascular inflammation and promote 
intravascular thromboses25, and that there is growing evidence which confirms that 
sleep-disordered breathing has direct proatherosclerotic effects and can exacerbate 
other cardiovascular risks26. But we have to exercise caution this holds a big trap: this 
study, like all others before it, makes no mention of nasal septal deformities in those 
patients. It does not mention any data regarding NSD in general, and furthermore, 
getting some idea about any of the particular types of NSD seems science fiction 
here! How is it possible to study patients suffering from CRS without mentioning any 
word on NSD or radiological findings? How reliable have all those CRS diagnoses 
been? Furthermore, it was obviously a retrospective matched-cohort study. For 
selection of the study cohort the authors first included 25673 subjects (!) who had 
received a first-time principal diagnosis of CRS. But who has given the diagnosis of 
CRS and how? This, of course, is not at all acceptable for any contemporary 
rhinologist. At the same time, to discuss an acute myocardial infarction without 
mentioning a coronarography finding is unacceptable for contemporary cardiologists. 
However, rhinologists are very well aware that CRS patients mentioned  
in this study have certainly had some septal deformity. Most recently, a large 
international study17 based on Mladina classification, proved this statement. It 
showed that the most frequent NSD among patients suffering from CRS were types 5 
(36.18%) and 7 (29.92%) and, in addition, it was found that the vast majority of those 
types 7 consisted of types 3 and, again, types 5 (76.32%). The rest were represented 
by other, pure types of deformities such as: type 1 showed up in only 1.53%, type 2 
in 3.05%, type 3 in 21.63, type 4 in 6.15% and type 6 in only 1.53%. Within this list of 
pure nasal septal deformities (i.e. isolated ones, not combined among themselves), 
type 3 has been found in more than one fifth of all! Already, at very first sight, it 
seems logical to expect type 3 in CRS patients: this type means vertical septal 
deflection at the borderline between perpendicular and quadrangular lamina, which 
produces unilateral narrowness of the nasal cavity resulting in distortion of 
physiologic laminar airstream into turbulent streams which produce essential change 
of the normal respiratory epithelium into multilayer squamous cell epithelium with no 
more cilia and mucociliary transport system. The mucociliary transport system is 
mandatory for the maintenance of healthy sinuses. The opposite, larger nasal cavity 
is not physiological either, since laminar airstream looses the maintenance from the 
septum, and, like in the narrow side, turns from laminar into turbulent streams as 
well. The result is the same: CRS. There is, however, another detail that has not 
been adequately emphasized but offers the answer to the enigma of the hypothetic 
influence of CRS on the acute coronary syndrome (ACS): type 5 NSD has been 
found as a pure type in 36.18% and as a part of type 7 in 76.32% of CRS cases!  The 
impact of the nasal obstruction and particular types of NSD to the cardiac pathology 
has obviously not been well studied yet, despite the fact that there is growing 
evidence that upper airway obstruction, on which NSD have an expected, profound 
influence, has a negative effect on cardiac function! The problem lies in the fact that 
none of the studies that investigated the relationship between the upper airway 
obstruction and cardiac function offered a systemic approach to the definition of the 
“upper airway obstruction”. What does it mean, this famous term? A nose full of 
polyps? A bilateral nasal septal deformity? A big antrochoanal polyp? An advanced 
vasomotor rhinopathy?  
The lack of this data in the “Material and methods” sections of the previous studies 
gives rise to the general mess in the interpretation of the results obtained so far. We 
still do not have a clear idea who or what exactly could be the rhinologic culprit (if 
any) for breakdowns in the cardiac system. Who or what exactly could be blamed for 
heart failure of whichever degree and type in cases of so called “upper airway 
obstruction”? 
Nasal septal deformities are well known as a factor that can remarkably and 
substantially affect the quality of nasal and pulmonary breathing. The etiology of the 
deformities is multifactorial, with trauma and genetics as leading factors27, 28. Nasal 
septal deformities appear in various forms, but there is still an obvious difference 
between particular types. This was first suggested and described by Mladina29. He 
defined seven types of NSD: four vertical (types 1 - 4), two horizontal (types 5 and 6) 
and their combination, i.e. type 7 (Figures. 1-5). Type 7 presents a combination of the 
previous types always following the same rule: one of the four vertical types is 
combined with type 5 or type 6, or, in extreme cases, with both of them. Because of 
this, every single type 7 is also very well defined. 
The incidence of NSD changes with age. Regarding children and adolescents (2-22 
yrs of age), the study by Šubarić and al.30 showed that the general incidence of nasal 
septal deformities was 28.9%, and the most frequent types of nasal septal 
deformities were types 1 (14.7%) and 2 (6.8%). Types 5 and 6 appeared in only 2.9% 
and 2.6%.  
Mladina and his group managed to show that the general incidence of NSD in adults 
was remarkably higher, i.e. almost 90%31. The most frequent types found were type 3 
(20.4%), type 2 (16.4%), type 1 (16.2%) and type 5, which appeared in 14% of 
investigated subjects. Type 6, however, was found in only 9.4% of them. According to 
these facts, the aggregate incidence of the incriminated two types (5 and 6) would be 
around 24.4% in the general ENT population in adults. 
Provided that the influence of NSD to the cardiac pathology is really so strong and 
fatal, almost 90% of the adult population in this world would be cardiac patients, 
which, fortunately, is not true at all. This gave a rise to the idea that maybe only some 
specific types of NSD have something to do with both the so called “upper airway 
obstruction” and/or cardiac function. But, if that is the case, what is the magic? 
It seems the magic is very simple: pure types 5 and 6, or type 7 which always 
consists of at least one of those two, flaringly dominate over other types of nasal 
septal deformities in patients who survived an ACS and later on showed a positive 
coronarography. 
ACS patients with a negative coronarography showed a predomination of vertical 
NSD like types 1, 2, 3 and 4 (78.34%). This finding suggests that types 5 and 6 
should be treated as a warning sign, the whistleblowers, that could alert doctors that 
their patient belongs to the group of people with a certain degree of predilection for 
the onset of ACS with positive coronarography. Thus, a hypothetic question arises 
here on whether horizontal deformities, i.e. types 5 and 6, play some role in the onset 
of ACS followed by positive coronarography or not? And, if yes, the much more 
important question is: what is the acting mechanism? Do they obstruct the nasal 
airway substantially, thus producing well known consequences regarding the heart 
function as it was stated so many times in literature so far, and most 
recently4,5,6,10,12,13 under the well known syntagm of obstructive sleep apnea 
syndrome (OSAS)?  
Numerous rhinomanometric studies have shown that vertical and horizontal nasal 
septal deformities contribute equally to the degree of impaired nasal breathing16. 
Unfortunately, again, none of these studies have been based on the Mladina 
classification, i.e. they terribly lack standardization in terms of “septal deviations”. 
That is why we cannot predicate that some of seven Mladina NSD types are the 
“rhinomanometric champions” and fateful for seriously impaired nasal breathing and 
health problems connected to this hypothetic “nasal obstruction” solution. Looking at 
it theoretically and logically, one could expect, in the case of a flaringly emphasized 
type 5 staying in more than close contact to the lateral nasal wall, a notable, but still 
only unilateral nasal obstruction. The same could be said of vertical deformities, like 
types 2 and 3, while only type 4 could, in emphasized cases, produce bilateral, real 
nasal obstruction. A pure type 6, in most of the cases, does not essentially influence 
the quality of nasal breathing. 
This would mean that perhaps, aside from the inherited appearance of the nasal 
septum in a particular individual, there is also an inherited affinity to the development 
of serious cardiac pathology accompanied by a positive coronarography. In terms of 
this, a meticulous anterior rhinoscopy as well as fiber-endoscopy of the nose should 
be added to the schedule of preventive cardiac examinations and tests.  
 
 
What is the future? 
In the future we need help from molecular biologists. Why? Because most probably 
there are some gene aberrations responsible for the onset of both types 5 and 6, and 
perhaps, at the same time, the same ones are responsible for the predisposition to 
the onset of ACS with positive coronarography finding. As we know, ACS happens to 
both those carrying types 5 or 6 and those who do not. The only difference is the 
positive coronarography in those carrying types 5 and 6, which means those with 
more severely damaged heart. We could presume that perhaps types 5 and 6 are 
just a balance cock: if one has type 5 or 6 nasal septal deformities, he or she could 
be more inclined to the onset of severe heart failure with the positive coronarography 
finding. If ACS and types 5 and 6 belong to the same gene family, ACS could be 
prevented due to future possibilities of gene therapy which will be able to eliminate 
the “bad guys” from the gene and thus eliminate the possibility of developing an ACS 
before it happens. Great hope regarding this appeared on the horizon very recently: 
A Chinese group of molecular biologists lead by Liang succeeded for the first time in 
human history to edit the genes of a human embryo32. The researchers from Sun 
Yat-Sen University in Guangzhou reportedly used the CRISPR/Cas9 technique to 
knock out a gene called HBB out of donor embryos, which causes the fatal blood 
disorder β-thalassaemia. This marks the first time that the CRISPR technique has 
been employed on an embryonic human genome. The Chinese colleagues found a 
way to prevent thalassemia in the embryonic stage, changing the gene structure in 
parents.   
In this case, all well known traditional risk factors such as family history, overweight 
body, smoking, stress, hypertension, hypercholesterolemia, diabetes mellitus, 
coronary artery calcium score, C-reactive protein, lipoprotein, homocysteine, 
lipoprotein-associated phospholipase A2, as well as high-density lipoprotein 
functionality, cannot account for the entire risk for incident coronary events. The fiber 
endoscopic examination of the nose, searching for type 5 or type 6 nasal septal 
deformities, will be added to the schedule of preventive cardiac examinations and 
tests. If so, they will be able to change human future: the number of heart failure 
caused deaths (like ACS) will dramatically decrease owing to the future possibilities 
of the gene therapy. Cardiovascular diseases (CVD) are now the leading cause of 
death worldwide. It continues to be on the rise and has become a true pandemic that 
has no respect for borders. Coronary artery disease  is the most common type of 
CVD. It continues to be the leading cause of mortality both in men and women in the 
U.S. Approximately every 25 seconds, an American will suffer an 
acute coronary syndrome, and approximately every minute someone will die of one33.  
In France, they are responsible for 142,000 deaths every year34. In terms of these 
data, human life in general could be substantially prolonged.  
 
 
In short, here are our hypotheses: 
1) There is a gene responsible for the development of type 5 and 6 nasal septal 
deformities. 
2) Since type 5 and 6 nasal septal deformities are flaringly frequent among patients 
who survived an ACS and showed positive coronarography finding, perhaps 
ACS with the positive coronarography and types 5 and 6 belong to the same 
gene family. 
3) ACS with the positive coronarography could be predicted in individuals carrying 
one or both of these types. 
4) In the years to come, the ACS with the positive coronarography finding could be 
also prevented owing to expected future possibilities of gene therapy which will 
be able to knock out the “bad guys” from the gene(s) and thus eliminate the 
possibility of developing an ACS before it happens.  
5) If so, molecular biologists will be able to change human future: the number of 
heart failure caused deaths will hopefully dramatically decrease and human life 
in general will be substantially prolonged; 
6) Anterior rhinoscopy regarding the search for the possible existence of type 6 and 
nasal endoscopy as the safest way to diagnose the existence of type 5 will be 
added to the schedule of preventive cardiac examinations and tests. 
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Figures legends: 
Fig. 1. A left sided type 3 septal deformity.  S-septum, IT-inferior turbinate, arrow-
middle turbinate 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Right nasal septal deformity during the native anterior rhinoscopy. The wast 
majority of the deformity is hidden by the head of the inferior turbinate. S-septum, IT-
inferior turbinate 
 
 
Fig. 3. Right nasal septal deformity after decongestion. The type 5 has been clearly 
identified (00 rigid endoscope view) S-septum. 
 
 
Fig. 4. Native anterior rhinoscopy presenting the left-sided type 2 septal deformity. S-
septum, IT-inferior turbinate  
 
 
Fig. 5 A). A native rhinoscopic view to the left-sided type 6 septal deformity. B) The 
typical gutter (white arrow) determines the side of the deformity which is entered into 
the documentation. IMBW- intermaxillary bone wing, PSE-palatal septal edge that 
has slipped into the right nasal cavity, out of the medial plane, LMT- left middle 
turbinate, RIT- right inferior turbinate. 
 
